Cite
HARVARD Citation
Kinch, A. et al. (2018). Long-term outcome of Epstein–Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT. Leukemia & lymphoma. 59 (5), pp. 1172-1179. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kinch, A. et al. (2018). Long-term outcome of Epstein–Barr virus DNAemia and PTLD with the use of preemptive rituximab following allogeneic HSCT. Leukemia & lymphoma. 59 (5), pp. 1172-1179. [Online].